Patrick Daly

DocwireNews

In a study, published in Annals of Emergency Medicine, researchers compared outcomes of intravenous thrombolysis with either tenecteplase or the current standard, alteplase, in initial treatment of acute ischemic stroke.Lead author of the study, Luke Murphy, reported initial stroke treatment with tenecteplase had lower rates of mortality, intracranial hemorrhage, and acute blood transfusion compared with alteplase. The authors noted their findings are in line with prior trials that showed tenecteplase had similar safety and efficacy but superior logistics compared with alteplase.The study reviewed 3432 patients treated with <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103909s5187lbl.pdf" target="_blank" rel="noopener">tenecteplase</a> and 55894 treated with alteplase for stroke at 54 centers after January 1, 2021 from within the retrospective TriNetX database.<h3>Authors Prefer Tenecteplase to Alteplase</h3>The final analysis was performed on propensity score-matched groups of 3432 patients each. Researchers assessed mortality, intracranial hemorrhage, and blood transfusions over the 7-day and 30-day periods following thrombolysis for <a href="https://www.docwirenews.com/post/stroke-risk-factors-despite-anticoagulation-in-patients-with-atrial-fibrillation">stroke treatment</a>.At day 30, authors stated patients treated with tenecteplase had a significantly lower mortality rate (8.2% vs 9.8%; risk ratio [RR], 0.832), and reduced risk of major bleeding events as defined by frequency of blood transfusions (0.3% vs 1.4%; RR, 0.207).The report noted that the primary cohort did not show a statistically significant difference in 30-day intracranial hemorrhage incidence (3.5% vs 3.0%; RR, 1.185. However, in a subgroup analysis of patients treated from 2021 to 2022, authors stated those treated with tenecteplase demonstrated improved survival and reduced intracranial hemorrhage compared with those treated with alteplase.Overall, the researchers concluded that &ldquo;the favorable mortality and safety profiles observed in this large study, taken together with previous randomized controlled trial data and operational advantages in rapid dosing and cost-effectiveness, all support the preferential use of tenecteplase in patients with ischemic stroke.&rdquo;Find More <a href="https://www.docwirenews.com/page/stroke">Research and Interviews on Stroke and Cardiology</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Tenecteplase Versus Alteplase: An Improved Standard for Stroke Treatment?

Stroke

Researchers compared intravenous thrombolysis with the conventional alteplase against thrombolysis with tenecteplase.

Tenecteplase Versus Alteplase: An Improved Standard for Stroke Treatment? 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe